Twin Path Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
TileBio develops self-supervised AI foundation models for digital pathology, applied to cancer diagnosis, prognosis, biomarker discovery, and drug development.
AI & Machine LearningBiotechDigital HealthMedical Devices
Christopher Walsh(Co-Founder / CEO & CTO)Ke Yuan(Co-Founder / CSO)inDavid Chang(Co-Founder / CMO)John Le Quesne(Co-Founder / CMO)
Co-investorsScottish Enterprise
Wholesum analyzes large volumes of open-ended, qualitative human responses using statistical inference and machine learning to surface patterns, risks, and early signals such as purchase intent and adoption barriers.
AI & Machine LearningData & InfrastructureEnterprise SoftwareMarketing Tech
Emily Kucharski(Co-founder & CEO)inAdam Kucharski(Co-founder)in
Co-investorsLove VenturesVentures Together
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.